摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-Methylundecan-1-ol | 91635-46-0

中文名称
——
中文别名
——
英文名称
9-Methylundecan-1-ol
英文别名
——
9-Methylundecan-1-ol化学式
CAS
91635-46-0
化学式
C12H26O
mdl
——
分子量
186.33
InChiKey
BPCAUKGHVSVGCW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    13
  • 可旋转键数:
    9
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

文献信息

  • Crystallizable polylactone copolymers prepared from mono- and di-functional polymerization initiators
    申请人:ETHICON, INC.
    公开号:EP1374921A1
    公开(公告)日:2004-01-02
    The present invention is directed to absorbable polylactone copolymers prepared in part from about 2 to about 80 mole percent glycolide, utilizing a combination of a monofunctional polymerization initiator and a di-functional polymerization initiator, to achieve rates of crystallization of the copolymer of at least about 2 times faster than the rate of crystallization of a copolymer made by a similar process utilizing either the mono-functional or the di-functional polymerization initiator alone. Medical devices containing such copolymers are also disclosed.
    本发明的目的是利用单官能团聚合引发剂和双官能团聚合引发剂的组合,制备部分由约 2 至约 80 摩尔百分数的羟基乙内酯组成的可吸收的聚乳酸共聚物,使共聚物的结晶速率比单独使用单官能团或双官能团聚合引发剂的类似工艺制作的共聚物的结晶速率至少快约 2 倍。此外,还公开了含有这种共聚物的医疗器械。
  • Liquid crystal compound
    申请人:TEIKOKU CHEMICAL INDUSTRY CO., LTD.
    公开号:EP0352054B1
    公开(公告)日:1993-02-10
  • Polymerization process using mono-and di-functional initiators to prepare fast crystallizing polylactone copolymers.
    申请人:ETHICON, INC.
    公开号:EP1375557B1
    公开(公告)日:2006-08-02
  • Polymerization process using mono-and di-functional initiators to prepare fast crystallizing polylactone copolymers
    申请人:ETHICON, INC.
    公开号:US20040006199A1
    公开(公告)日:2004-01-08
    The present invention is directed to a process for making an absorbable polylactone copolymer prepared in part from about 2 to about 80 mole percent glycolide, which process utilizes a combination of a monofunctional polymerization initiator and a di-functional polymerization initiator, to achieve rates of crystallization of the copolymer of at least about 2 times faster than the rate of crystallization of a copolymer made by a similar process utilizing either the mono-functional or the di-functional polymerization initiator alone. Absorbable polylactone copolymers prepared by such processes and medical devices containing such copolymers are also disclosed.
  • US6794484B2
    申请人:——
    公开号:US6794484B2
    公开(公告)日:2004-09-21
查看更多